15.03.2012 13:20 Uhr, Quelle: Wallstreet online

Heptares to Present at 6th Annual BIO-Europe Spring Conference on 20 March 2012

WELWYN GARDEN CITY, England and BOSTON, March 15, 2012 /PRNewswire/ Heptares Therapeutics, the leading GPCR drug discovery company, announces that its Chief Business Officer, Barry Kenny, will present overview of the Company at 09:45am CET …

Weiterlesen bei Wallstreet online